These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5100499)

  • 1. Intraperitoneal insulin for control of blood sugar in diabetic patients during peritoneal dialysis.
    Crossley K; Kjellstrand CM
    Br Med J; 1971 Jan; 1(5743):269-70. PubMed ID: 5100499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
    Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal administration of insulin during peritoneal dialysis of diabetics with terminal renal failure.
    Anderson KE; Petersen PH
    Int J Artif Organs; 1981 Jul; 4(4):162-7. PubMed ID: 7035377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
    García Ortiz R; Gómez M; Olea C
    Rev Med Chil; 1989 Dec; 117(12):1367-73. PubMed ID: 2519375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients.
    Oba I; Mori T; Chida M; Kurasawa N; Naganuma E; Sato E; Koizumi K; Sato S; Tsuchikawa M; Ito S
    Adv Perit Dial; 2015; 31():11-6. PubMed ID: 26714381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peritoneal absorption of insulin in diabetic man: a potential site for a mechanical insulin delivery system.
    Schade DS; Eaton RP; Spencer W; Goldman R; Corbett WT
    Metabolism; 1979 Mar; 28(3):195-7. PubMed ID: 763154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal insulin in diabetic CAPD patients.
    Mactier RA; Khanna R
    Int J Artif Organs; 1988 Jan; 11(1):9-12. PubMed ID: 3283057
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
    Mactier RA; Moore H; Khanna R; Shah J
    Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intraperitoneal insulin regimen for diabetics on continuous cyclic peritoneal dialysis.
    Aujla NS; Piraino B; Sorkin MI
    ASAIO Trans; 1990; 36(2):119-21. PubMed ID: 2187506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimate the insulin absorption in diabetic patients on peritoneal dialysis.
    Pantsulaia T; Chokhonelidze I; Lomitashvili T
    Georgian Med News; 2006 Nov; (140):28-30. PubMed ID: 17179582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal insulin in the diabetic continuous ambulatory peritoneal dialysis (CAPD) patient - nursing management.
    Adair CM
    AANNT J; 1982 Apr; 9(2):62-3. PubMed ID: 7039632
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraperitoneal versus subcutaneous insulin in patients on nighttime IPD.
    Bargman JM
    Adv Perit Dial; 1994; 10():116-9. PubMed ID: 7999807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
    Riambau E; Aubia J; Llorach I; Lloveras J; Masramón J; Orfila A; Llorach M
    Rev Clin Esp; 1982 Mar; 164(5):333-4. PubMed ID: 7048442
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
    N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose, insulin and C-peptide kinetics during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Smeby LC; Myking OL; Wessel-Aas T
    Proc Eur Dial Transplant Assoc; 1983; 20():195-200. PubMed ID: 6361735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three diabetic peritoneal dialysis patients receiving intraperitoneal insulin with dosage adjustment based on capillary glucose levels during peritoneal equilibrium tests.
    Thorp ML; Wilks TS
    Am J Kidney Dis; 2004 May; 43(5):927-9. PubMed ID: 15112185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of terminal renal failure in diabetic patients by regular dialysis therapy.
    White N; Snowden SA; Parsons V; Sheldon J; Bewick M
    Nephron; 1973; 11(5):261-75. PubMed ID: 4753518
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategies for managing diabetic patients on peritoneal dialysis.
    Dasgupta MK
    Adv Perit Dial; 2004; 20():200-2. PubMed ID: 15384826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients: Associations with Body Composition, Peritoneal Transport, and Peritoneal Glucose Absorption.
    Bernardo AP; Oliveira JC; Santos O; Carvalho MJ; Cabrita A; Rodrigues A
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2205-12. PubMed ID: 26507143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.